LISTEN LIVE: Loading...

Advertisement

 

South African study finds Pfizer vaccine stops 70% of hospitalizations from omicron

05:07
Download
Play
This article is more than 1 year old.

A new study out of South Africa found that Pfizer's mRNA vaccine offered only 30% protection against infection by the omicron variant, but it did offer 70% protection against severe disease.

Pfizer also released new data showing its COVID-19 pill was effective in preventing hospitalization and death.

Here & Now's Scott Tong speaks with Dr. Angela Rasmussen, a virologist at the vaccine and infectious disease organization at the University of Saskatchewan.

This segment aired on December 14, 2021.

Advertisement

 
Play
Listen Live
/00:00
Close